Chemo Pharma Laboratories Share Price

  • 66.00-2.95 (-4.27%)
  • Volume: 902
BSE
  • Closed
  • Last Updated On: 28 Jun, 2024, 03:31 PM IST
STOCK SCORE
ETPrime Only
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • TECHNICALS
  • COMPARE
Loading...

Chemo Pharma Laboratori...

  • 66.00-2.95 (-4.27%)
  • Volume: 902
Advertisment

Chemo Pharma share price insights

View All

  • Company has no debt since last 5 years. (Source: Standalone Financials)

  • Company has posted a loss of Rs 0.29 cr in 31 Mar, 2024 quarter after 3 consecutive quarter of profits. (Source: Standalone Financials)

  • Stock gave a 3 year return of 127.59% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)

  • Company's annual revenue growth of 522.83% outperformed its 3 year CAGR of 39.66%. (Source: Standalone Financials)

  • Chemo Pharma Laboratories Ltd. share price moved down by -4.27% from its previous close of Rs 68.95. Chemo Pharma Laboratories Ltd. stock last traded price is 66.00

    Share PriceValue
    Today/Current/Last-66.00
    Previous Day-68.95

InsightsChemo Pharma

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)    		8.62
    EPS - TTM
    (₹)    		8.00
    MCap
    (₹ Cr.)    		10.34
    Sectoral MCap Rank
    		165
    PB Ratio
    (x)    		0.81
    Div Yield
    (%)    		0.00
    Face Value
    (₹)    		10.00
    Beta

    Beta

    1 Month0.02
    3 Months0.10
    6 Months0.01
    1 Year-0.01
    3 Years-0.01

    		0.02
    VWAP
    (₹)    		65.85
    52W H/L
    (₹)
    87.00 / 27.17

    Chemo Pharma Share Price Returns

    1 Day-4.27%
    1 Week7.49%
    1 Month-12.54%
    3 Months1.54%
    1 Year93.27%
    3 Years155.81%
    5 YearsN.A.

    ET Stock ScreenersTop Score Companies

    Check whether Chemo Pharma belongs to analysts' top-rated companies list?

    View Stock Screeners

    Chemo Pharma News & Analysis

    View all Chemo Pharma Share News & Announcements

    Chemo Pharma Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Chemo Pharma Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Chemo Pharma Financials

    • Income (P&L)

    • Balance Sheet

    • Cash Flow

    • Ratios

    • Insights

      • PAT: Slipping to Red

        Company has posted a loss of Rs 0.29 cr in 31 Mar, 2024 quarter after 3 consecutive quarter of profits. (Source: Standalone Financials)

      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 522.83% outperformed its 3 year CAGR of 39.66%. (Source: Standalone Financials)
      Quarterly | AnnualMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
      Total Income0.250.700.460.43-0.10
      Total Income Growth (%)-64.8952.717.10-542.22-151.98
      Total Expenses0.100.030.020.050.02
      Total Expenses Growth (%)268.9925.85-61.39128.88-6.83
      EBIT0.150.680.440.38-0.12
      EBIT Growth (%)-77.6253.9616.77--174.31
      Profit after Tax (PAT)-0.290.680.440.38-0.15
      PAT Growth (%)-143.1053.8716.77--191.41
      EBIT Margin (%)61.3996.3395.5487.63123.89
      Net Profit Margin (%)-118.1796.2795.5487.63152.42
      Basic EPS (₹)-1.944.512.932.51-0.99
      Annual FY 2016
      Total Revenue0.49
      Total Revenue Growth (%)-
      Total Expenses1.84
      Total Expenses Growth (%)-
      Profit after Tax (PAT)-1.45
      PAT Growth (%)-
      Operating Profit Margin (%)0.00
      Net Profit Margin (%)0.00
      Basic EPS (₹)-9.66
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue1.840.300.790.671.00
      Total Revenue Growth (%)522.83-62.5918.10-32.9821.18
      Total Expenses0.190.220.420.360.50
      Total Expenses Growth (%)-12.32-47.6518.66-28.91-11.50
      Profit after Tax (PAT)1.200.050.560.250.42
      PAT Growth (%)2,437.68-91.55123.91-39.76101.25
      Operating Profit Margin (%)0.000.000.000.000.00
      Net Profit Margin (%)0.000.000.000.000.00
      Basic EPS (₹)8.000.323.731.672.77

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Profit & Loss Statement are available.

    • Insights

      • Zero Debt Burden

        Company has no debt since last 5 years. (Source: Standalone Financials)
      Annual FY 2016
      Total Assets3.87
      Total Assets Growth (%)-
      Total Liabilities0.20
      Total Liabilities Growth (%)-
      Total Equity3.67
      Total Equity Growth (%)-
      Current Ratio (x)28.82
      Total Debt to Equity (x)0.00
      Contingent Liabilities-
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets13.0211.6211.6611.0510.97
      Total Assets Growth (%)12.05-0.345.520.735.28
      Total Liabilities0.210.020.110.060.22
      Total Liabilities Growth (%)950.00-81.8283.33-72.73144.44
      Total Equity12.8011.6011.5510.9910.74
      Total Equity Growth (%)10.340.435.102.333.97
      Current Ratio (x)35.09306.6758.17187.5340.32
      Total Debt to Equity (x)0.000.000.000.000.00
      Contingent Liabilities0.00-0.11--

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2016
      Net Cash flow from Operating Activities-2.09
      Net Cash used in Investing Activities2.15
      Net Cash flow from Financing Activities0.00
      Net Cash Flow0.06
      Closing Cash & Cash Equivalent0.44
      Closing Cash & Cash Equivalent Growth (%)-
      Total Debt/ CFO (x)0.00
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities0.89-0.68-0.331.554.83
      Net Cash used in Investing Activities-0.690.630.970.511.01
      Net Cash flow from Financing Activities-0.15-0.08-2.12--
      Net Cash Flow0.05-0.13-1.492.065.84
      Closing Cash & Cash Equivalent0.610.560.6910.878.81
      Closing Cash & Cash Equivalent Growth (%)8.99-18.96-93.6923.421,789.59
      Total Debt/ CFO (x)0.000.000.000.000.00

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2016
      Return on Equity (%)-39.44
      Return on Capital Employed (%)-35.51
      Return on Assets (%)-37.44
      Interest Coverage Ratio (x)0.00
      Asset Turnover Ratio (x)0.00
      Price to Earnings (x)-1.85
      Price to Book (x)0.73
      EV/EBITDA (x)-1.66
      EBITDA Margin (%)0.00
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)9.370.404.842.273.86
      Return on Capital Employed (%)12.800.633.152.824.59
      Return on Assets (%)9.220.404.802.263.78
      Interest Coverage Ratio (x)0.000.000.000.000.00
      Asset Turnover Ratio (x)---0.000.00
      Price to Earnings (x)8.12128.2111.0710.722.35
      Price to Book (x)0.760.520.540.240.09
      EV/EBITDA (x)2.21-0.820.02-24.49-15.14
      EBITDA Margin (%)0.000.000.000.000.00

    Financial InsightsChemo Pharma

    • Income (P&L)
    • Balance Sheet

      • PAT: Slipping to Red

        Company has posted a loss of Rs 0.29 cr in 31 Mar, 2024 quarter after 3 consecutive quarter of profits. (Source: Standalone Financials)

      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 522.83% outperformed its 3 year CAGR of 39.66%. (Source: Standalone Financials)

      • Zero Debt Burden

        Company has no debt since last 5 years. (Source: Standalone Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Chemo Pharma Peer Comparison

    • Chemo Pharma Stock Performance

    • Ratio Performance

      • CHART
      • TABLE

      Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of 127.59% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)

      • Stock Returns vs Nifty Pharma

        Stock generated 127.59% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

      • Choose from Peers

          Choose from Stocks

          • 1D
          • 1W
          • 1M
          • 3M
          • 6M
          • 1Y
          • 5Y
          Loading...

        • Insights

          • Stock Returns vs Nifty Smallcap 100

            Stock gave a 3 year return of 127.59% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)

          • Stock Returns vs Nifty Pharma

            Stock generated 127.59% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

          Ratio Performance

          NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
          Chemo Pharma8.620.819.3712.809.2239.660.000.008.0035.090.000.00
          Unjha Form43.434.4210.1718.545.6321.842.741.500.621.740.000.00
          Parmax Pharma-2.02110.71-5,458.99-82.27-37.51-24.76-45.54-52.02-15.370.6356.07-30.10
          Norris Medicine-9.71-0.850.00-14.67-8.38-22.59-12.91-21.05-1.190.67-1.5863.68
          Colinz Labs21.721.185.437.494.284.739.786.921.934.000.060.55
          Add More
          Annual Ratios (%)

          Choose from Peers

          • Avon Lifesciences
          • Brawn Biotech
          • Kamron Labs.
          • Welcure Drugs
          • Advik Labs

          Choose from Stocks

            See All Parameters

          Peers InsightsChemo Pharma

          • Stock Returns vs Nifty Smallcap 100

            Stock gave a 3 year return of 127.59% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)

          • Stock Returns vs Nifty Pharma

            Stock generated 127.59% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

          Do you find these insights useful?

          • hate it

          • meh

          • love it

          Chemo Pharma Shareholding Pattern

          • QOQ Change

          • Total Shareholdings

          • Loading...
            Showing Chemo Pharma Shareholding as on 31 Mar 2024
            Category31 Mar 202431 Dec 202330 Sep 202330 Jun 2023
            Promoters27.8927.8927.8927.89
            Pledge0.000.000.000.00
            FII0.000.000.000.00
            DII0.000.000.000.00
            Mutual Funds0.000.000.000.00
            Others72.1172.1172.1172.11
          • Showing Shareholding as on 31 Mar 2024
            CategoryNo. of SharesPercentage% Change QoQ
            Promoters4,18,28127.89 %0.00
            Pledge00.00 %0.00
            Others10,81,71972.11 %0.00

          MF Ownership

          MF Ownership details are not available.

          Top Searches:

          Chemo Pharma News Chemo Pharma Quarterly Results Chemo Pharma Dividend Chemo Pharma Q1 ResultsChemo Pharma Q2 ResultsChemo Pharma Q3 ResultsChemo Pharma Q4 Results

          Corporate Actions

          • Chemo Pharma Board Meeting/AGM

          • Chemo Pharma Dividends

          • Others
          • Meeting DateAnnounced onPurposeDetails
            May 27, 2024May 10, 2024Board MeetingAudited Results
            Jan 29, 2024Jan 09, 2024Board MeetingQuarterly Results & Others
            Oct 27, 2023Oct 16, 2023Board MeetingQuarterly Results
            Sep 25, 2023Jul 27, 2023AGMA.G.M.
            Jul 27, 2023Jul 14, 2023Board MeetingQuarterly Results & Others

          • Dividend announcements are not available.

          • All TypesEx-DateRecord DateAnnounced onDetails
            RightsOct 08, 1991Nov 11, 1991Sep 30, 1991Rights ratio: 1 share for every 2 held at a price of Rs 10.0

          About Chemo Pharma

          • Executives

          • Auditors

          • BS

            Bhavin Sheth

            Executive Director & CEO
            AS

            Ashok Somani

            Executive Director & CFO
            SS

            Shanta Somani

            Non Executive Director
            MP

            Mathura Prasad Sharma

            Independent Director
            Show More
          • Sanjay Rane & Associates
            VMD & Co

          Industry

          Pharma - Indian

          Key Indices Listed on

          -

          Address

          5, Kumud Apartment CHS Ltd.,Karnik Road, Chikan Ghar,Kalyan,Thane District, Maharashtra - 421301

          Contact

          [email protected]

          http://www.thechemopharmalaboratoriesltd.com

          More Details

          FAQs about Chemo Pharma share

          • 1. What's Chemo Pharma share price today and what are Chemo Pharma share returns ?
            Chemo Pharma share price was Rs 66.00 as on 28 Jun, 2024, 03:31 PM IST. Chemo Pharma share price was down by 4.27% based on previous share price of Rs 66.93. Chemo Pharma share price trend:
            • Last 1 Month: Chemo Pharma share price moved down by 12.54%
            • Last 3 Months: Chemo Pharma share price moved up by 1.54%
            • Last 12 Months: Chemo Pharma share price moved up 93.27%
            • Last 3 Years: Chemo Pharma Share price moved up by 155.81%
          • 2. Who is the Chief Executive Officer of Chemo Pharma?
            Bhavin Sheth is the Executive Director & CEO of Chemo Pharma
          • 3. Which are the key peers to Chemo Pharma?
            Within Pharmaceuticals sector Chemo Pharma, Kobo Biotech Ltd., Colinz Laboratories Ltd., Parmax Pharma Ltd., Norris Medicines Ltd., Brawn Biotech Ltd., Unjha Formulations Ltd., Welcure Drugs & Pharmaceuticals Ltd., Adline Chem Lab Ltd., MPS Pharma Ltd. and Shyama Infosys Ltd. are usually compared together by investors for analysis.
          • 4. What are the returns for Chemo Pharma share?
            Return Performance of Chemo Pharma Shares:
            • 1 Week: Chemo Pharma share price moved up by 7.49%
            • 1 Month: Chemo Pharma share price moved down by 12.54%
            • 3 Month: Chemo Pharma share price moved up by 1.54%
            • 6 Month: Chemo Pharma share price moved up by 4.76%
          • 5. What is 52 week high/low of Chemo Pharma share price?
            In last 52 weeks Chemo Pharma share had a high price of Rs 87.00 and low price of Rs 27.17
          • 6. What are the Chemo Pharma quarterly results?
            Total Revenue and Earning for Chemo Pharma for the year ending 2024-03-31 was Rs 1.84 Cr and Rs 1.20 Cr on Standalone basis. Last Quarter 2024-03-31, Chemo Pharma reported an income of Rs 0.25 Cr and loss of Rs -0.29 Cr.
          • 7. What's the market capitalization of Chemo Pharma?
            Market Capitalization of Chemo Pharma stock is Rs 10.34 Cr.
          • 8. What are the key metrics to analyse Chemo Pharma Share Price?
            Chemo Pharma share can be quickly analyzed on following metrics:
            • Stock's PE is 8.62
            • Price to Book Ratio of 0.81
          • 9. Who's the owner of Chemo Pharma?
              • Promoter holding has not changed in last 9 months and holds 27.89 stake as on 31 Mar 2024
              • Other investor holding has not changed in last 9 months and holds 72.11 stake as on 31 Mar 2024
          • 10. What is the PE & PB ratio of Chemo Pharma?
            The PE ratio of Chemo Pharma stands at 8.62, while the PB ratio is 0.81.

          Trending in Markets

          DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

          DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

          By using this site, you agree to the Terms of Service and Privacy Policy.

          Business News›Markets›Stocks›Stock Price Quotes›Chemo Pharma Share Price
          The Economic Times